Market closed
$
14.31
Change
-1.06 -6.90%
Volume
Volume 658,385
Mar 5, 2021, 4:00 p.m.
Quotes are delayed by 20 min
Previous close
$ 15.37
$ 14.31
Change
-1.06 -6.90%
Day low
Day high
$12.60
$15.29

52 week low
52 week high
$2.20
$29.99

Market cap
$213.69M
Average volume
404,798
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-0.97
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on INMB
-
INmune Bio stock price target raised to $32 from $16 at Maxim Group
- Tomi Kilgore
-
INmune Bios started at buy with $13 stock price target at Maxim Group
- Tomi Kilgore
Other News on INMB
-
- Edgar Online - (EDG = 10Q, 10K)
-
PTON ,U among premarket losers
- Seeking Alpha
-
CLSN, RIOT, POLA and MARA among midday movers
- Seeking Alpha
-
JAGX, TELL, CRDF and DTIL among premarkets gainers
- Seeking Alpha
-
- Seeking Alpha
-
INmune Bio (INMB) Investor Presentation - Slideshow
- Seeking Alpha
-
INmune Bio receives patent for covering INKmune therapy
- Seeking Alpha
-
INmune Bio nabs European patent for XPro1595
- Seeking Alpha
-
HTBX, DGLY, CLNY and RYCE among midday movers
- Seeking Alpha
-
- Seeking Alpha
-
- Seeking Alpha
-
INmune Bio: Stronger Support From Alzheimer's Drug XPro1595
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
Press Releases on INMB
-
InvestorNewsBreaks - INmune Bio Inc. (NASDAQ: INMB) Featured by M-Vest
- Investor Brand Network
-
European Patent Granted Covering INmune Bio's XPro1595
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com